MTD

Mettler-Toledo International, IHealthcare / Diagnostics & ResearchINTACT

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

Share Price
$1299.29
52W: $1023.05 - $1525.17
DCF Fair Value
$901.85
-44.1% Premium
P/E (TTM)
29.3x
ROIC
23.4%
Operating Margin
31.2%
FCF Yield
2.7%
Debt / Equity
166.68x
Piotroski Score
6/9
Altman Z-Score
3.2
Market Cap
$26B

Price vs. Intrinsic Value Corridor

Overvalued vs DCF ($901.85)

Historical market price overlaid against conservative DCF Fair Value & Benjamin Graham Margin of Safety bands.

Period Return (1Y)
()
Period Range
$ - $
DCF Fair Value
$901.85
MOS Buy Target (-25%)
$676.39
Valuation Overlays:

2-Stage Discounted Cash Flow (DCF) Workbench

Conservative intrinsic value model based on owner cash generation over a 10-year investment horizon. Opens with LocalAlpha's baseline assumptions (matching the fair value shown above) — adjust any input to stress-test.

Current Market Price
$1299.29
DCF Fair Value
$907.80
-43.1% Premium
$694M
$100M$694M (Reported)$50,000M
15.6%
-5%10% (Target)35%
4.5%
0%5%20%
9.0%
6%9% (Standard)15% (High Risk)
2.5%
1% (GDP Floor)2.5% (Inflation)4.0%
$2,000M
-$100B CashBalance Sheet+$150B Debt
10-Yr PV of Cash Flows
$8.3B
PV of Terminal Value
$11.9B
Implied Enterprise Value
$20.2B
Implied Equity Value
$18.2B
YearYr 1Yr 2Yr 3Yr 4Yr 5Yr 6Yr 7Yr 8Yr 9Yr 10
Projected FCF ($M)$802$927$1,072$1,239$1,433$1,497$1,565$1,635$1,709$1,785
Present Value (PV)$736$781$828$878$931$893$856$821$787$754

Benjamin Graham & Buffett Value Models

Classical deep value metrics based on asset backing, normalized earnings power, and owner cash yield.

Graham Number-5043.7% Premium
$25.26

Calculated as √(22.5 × EPS × BVPS). The maximum theoretical price a defensive investor should pay based purely on asset book value and current earnings.

EPS: $44.31BVPS: $0.64
Revised Graham Formula-0.3% Premium
$1295.70

Formula: V = (EPS × (8.5 + 2g) × 4.4) / Y where g is the conservative 7-10 yr growth rate and Y is AAA Bond Yield.

Buffett Owner Earnings2.5% Yield
$32.96 / share

True distributable cash flow: Net Income + D&A - Maintenance CapEx. Reflects the cash Buffett would extract without hurting unit volume.

Total: $0.7BYield: 2.5%

Reverse DCF: Market Growth Expectation

FAIR BARRIER
13.9% CAGR (Next 10 Yrs)

At the current price of $1299.29, the market is assuming the business will compound Free Cash Flow at 13.9% per year for the next decade with a 9% hurdle rate.

Value Investor Verdict
ℹ Fair expectations: Requires steady execution.
Autonomous Thesis Underwriting

Surveil MTD with Mathematical Margin of Safety Rules

Set non-negotiable floor rules for Mettler-Toledo International, I. If a newly filed quarterly 10-Q breaks your ROIC floor, operating margin boundary, or balance sheet leverage rules, receive an autonomous breach audit within 15 minutes.

Buffett Quality

ROIC > 15% • Margin > 15% • D/E < 0.5x

Margin Floor Guard

Current Margin 31.2% • Floor > 10%

Solvency Guard

Altman-Z > 2.6 • Current Ratio > 1.5x

Frequently Asked Questions: Mettler-Toledo International, I (MTD) Intrinsic Valuation

Audited fundamentals, DCF intrinsic value sensitivity, and thesis break detection parameters for Mettler-Toledo International, I.

Based on institutional multi-stage Discounted Cash Flow (DCF) modeling on audited SEC cash flows, Mettler-Toledo International, I has an estimated DCF intrinsic fair value of $901.85 per share compared to its current market price of $1299.29. This represents an estimated 44.1% premium over fair value. Additionally, its classic Benjamin Graham Number stands at $25.26.

Related Healthcare Value Stocks & Sector Peers

Compare Mettler-Toledo International, I with audited intrinsic valuation models across the Healthcare sector.

View All S&P 500 Stocks